Product Images Lacosamide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Lacosamide NDC 14445-131 by Indoco Remedies Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text seems to be a description of a medication called Lacosamide Tablets, USP. It provides information on the usual dosage and storage requirements. It also includes a pharmaceutical code and the National Drug Code (NDC) number for the product. The text mentions the USP controls and a room temperature requirement. The medication may be prescribed to address stress and formation concerns. The last line seems to be the size of the tablet, 45 x 15 mm.*
Each tablet contains 50 mg of Lacosamide, a medication used to treat seizures. It is manufactured by Inbog Remedies Ltd. The product is packaged as 60 tablets and is only available with a prescription. There are also instructions for storage and usage.*
This is a description for the medication Lacosamide. It comes in tablet form with each tablet containing 200mg of Lacosamide, USP. The recommended dosage information can be found in the package insert. The tablets should be stored at room temperature between 15 to 30°C. Each bottle contains 60 tablets and is for prescription only. The medication guide that comes with the tablets must be handed to the patient.*
Lacosamide Tablets, USP contain 50mg of Lacosamide. The usual dosage can be found in the package insert. The tablets should be stored between 20-25°C (68-77°F) and excursions are permitted between 18-30°C (89-106°F). The tablets are for Rx-only and are supplied in a bottle of 60 tablets. Pharmacists should ensure that each patient receives the accompanying Medication Guide. The NDC is 14445-129-60. The rest of the text contains non-English characters and so is not available.*
This table shows the responder rate, improvement, and worsening based on the number of patients taking different doses of Lacosamide Tablets or placebo. The table does not provide any further context or information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.